The new crown variant Arcturus|The number of cases in the United States doubled last week, and the high infectivity may cause conjunctivitis in young patients (18:04)

Arcturus (official name XBB.1.16) is spreading rapidly around the world. It accounted for only 0.21% of the global cases at the end of February, and it has risen to 3.96% one month later. The WHO has listed Arcturus as “positive” since March 22. Virus strains for further monitoring” (Variants-Under-Monitoring). The Ministry of Health of India announced on Sunday (16th) that there were 10,093 new cases within 24 hours, which was the fourth consecutive day that more than 10,000 new cases were added. The positive rate was 5.61%, and 19 people died. Officials of the Ministry of Health predicted that the number of confirmed cases may continue to increase in the next 10 to 12 days, but reiterated that the demand for hospital beds is not under pressure, and the public does not need to panic.

U.S. infections with Arcturus also doubled last week, with an estimated 7.2% of coronavirus samples from April 9-15 being Arcturus, up from 3.9% the previous week.

Experts at the Mayo Clinic in the United States say Arcturus is more transmissible than previous strains, but believes it has not become more dangerous. Arcturus appears to cause conjunctivitis, or red, itchy eyes, in younger patients, said Matthew Binnicker, director of Mayo Clinic’s clinical virology laboratory.

(Forbes/Daily Voice/CNA)

Related reports on the new crown mutant strain Arcturus:

Xu Shuchang: Oral medicines are still effective for foreign children with corneal inflammation after being infected with Arcturus